Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025.
- The company said it achieved the goal of $4 bln in cost savings through 2024 and anticipates an additional $500 mln in savings in 2025, from the ongoing cost realignment program
- Pfizer continues to expect fiscal 2024 revenue in the range of $61 billion to $64 billion and confirmed its full-year adjusted EPS guidance of $2.75-2.95
- For fiscal 2025, the management expects revenue to be in the range of $61 billion to $64 billion and adjusted EPS between $2.80 and $3.00
- It is looking for adjusted EPS operational growth of 10-18% for FY25, from the midpoint of the 2024 guidance after adjusting for non-recurring items
- Phase I of the company’s manufacturing optimization program is on track to deliver initial net cost savings in the latter part of 2025, towards the goal of improving gross margin performance
- Adjusted SI&A expense is expected to be in the range of $13.3 to $14.3 billion in FY25, and adjusted R&D expenses between $10.7 billion and $11.7 billion
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Citigroup set to report Q4 2025 earnings. Here’s what to expect
Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the
Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon
Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to
